France / Français
Master Doctor Search: Nutrition - Fitness > Hematology-Oncology
Combo Therapy for Advanced NSCLC Provides PFS Benefit
1 month ago - By Medscape
Combining a TKI with chemo or an antiangiogenic agent may prolong PFS in advanced NSCLC with certain mutations. The study was published as a preprint and has not yet been peer reviewed.
First Look
Read more ...Long-Term Data Reinforce Targeted Combo Versus Single Agent for Advanced Melanoma
1 month ago - By MedPageToday
Combination targeted therapy significantly improved 5-year progression-free survival and overall survival versus single-agent vemurafenib and was numerically superior to single-agent encorafenib (Braftovi...
Read more ...
Search by Tags
Hematology-Oncology News
The headlines of Master Doctor
Patients who are underweight, overweight or obese at increased risk for AKI
Patients who were obese, overweight or underweight were at an increased risk for AKI, compared with patients who had a normal BMI, according to data published in the Journal of...
CDC surveillance program allows government to track unvaccinated people when...
Exclusive video footage and bombshell federal government records show that the U.S. Centers for Disease Control and Prevention is now actively tracking people who just said no...